Gastrointestinal Stromal Tumor (GIST)
Showing NaN - NaN of 4
Gastrointestinal Stromal Tumor (GIST) Trial in New York (drug, other, procedure)
Active, not recruiting
- Gastrointestinal Stromal Tumor (GIST)
- MEK162
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Dec 28, 2022
Gastrointestinal Stromal Tumor (GIST) Trial in New York (MEK162, Pexidartinib)
Completed
- Gastrointestinal Stromal Tumor (GIST)
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Apr 29, 2021
Melanoma, NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial in United States (PLX3397, Pembrolizumab)
Gastrointestinal Stromal Tumor (GIST) Trial in United States (imatinib mesylate)
Completed
- Gastrointestinal Stromal Tumor (GIST)
- imatinib mesylate
-
La Jolla, California
- +20 more
Mar 9, 2018